Recent news on Zyvox

Researchers Discover How Antibiotic Inhibits Bacterial Growth  -  May 11, 2007
MedIndia,It is marketed in the United States as Zyvox. Mankin and his colleagues managed not only to crosslink the drug to its target in the living cell,

Resisting the call for new antibacterials?  -  Apr 30, 2007
In-PharmaTechnologist.com,Zyvox, launched in 2001, was the first truly new molecular entity to be launched after an innovation gap of several decades and opened a new class of

Targanta Seeks $86M In IPO For Antibiotic Development  -  May 14, 2007
BioWorld Online,Vancomycin accounts for about 85 percent of those courses of therapy, with Zyvox (linezolid, Pfizer Inc.) and Cubicin (daptomycin for injection,

Astellas Pharma: telavancin enters EU battle for MRSA market share  -  May 2, 2007
Pharmaceutical Business ReviewIf approved, telavancin will enter the market behind a number of key competitors: Pfizer’s Zyvox, (linezolid) first launched in the EU in 2001 (and is

Zyvox(TM) Inventors Win Discoverers Award  -  Mar 28, 2007
Drug Newswire (press release),Pfizer, Inc's revolutionary Zyvox(TM) is the first medicine in a new class of antibiotics that helps treat life-threatening infections caused by highly

Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief ...  -  Apr 2, 2007
CNW Telbec (Communiqués de presse),Zyvox is an antibiotic specifically designed to address some of the most important problems in treating multiple drug resistant bacterial infections.

In 2005 The Global Antibacterial Market Was Valued At ...  -  Apr 5, 2007
Genetic Engineering News (press release),The fastest growing classes were the carbapenems, glycopeptides and "others" (eg Pfizers Zyvox (linezolid)). The best selling drug was J&Js/Sanofi-Aventis

Bacteria mutateto counter antibiotics  -  Apr 22, 2007
Orlando Sentinel,A new drug, Zyvox, is being used, but if history is any predictor, it is only a matter of time before some staph become resistant to this as well.

Aggressive Screening For 'Superbugs' In Children  -  Apr 20, 2007
Medical News Today (press release),Vancomycin (Vancocin) is currently the only FDA-approved drug for MRSA in children, and only one drug, linezolid (Zyvox), is approved in pediatrics for VRE.

Pfizer Delivers Solid First-Quarter 2007 Results, Updates Full ...  -  Apr 20, 2007
PharmaLive.com (press release),Detrol (up 17 percent), Zyvox (up 39 percent), Vfend (up 26 percent), Viagra (up 11 percent), Zyrtec (up 10 percent), and Aromasin (up 33 percent),

GSK meet no resistance for new antibacterial  -  Apr 16, 2007
DrugResearcher.com,In recent months, new antibiotics from the likes of Wyeth (Tygacil; tigecycline) Pfizer (Zyvox; linezolid) and Novartis/Cubist (Cubicin; daptomycin) have

FDA Warns About Risk of Linezolid (Zyvox) for Septicemia  -  Mar 20, 2007
MedPage Today,ROCKVILLE, Md., March 20 -- The FDA has issued a safety alert for linezolid (Zyvox) after clinical trial data the suggested excess mortality when the drug

New Zyvox Safety Concerns  -  Mar 20, 2007
Facts and Comparisons,Health care professionals are being notified by the FDA of emerging safety concerns about Zyvox (linezolid). A recent, open-label, randomized trial compared

FDA issues safety alert on Pfizer's Zyvox  -  Mar 19, 2007
Pharma Times (subscription),US regulators have issued a safety alert about Pfizer's antibiotic Zyvox after a recent trial found a higher chance of death in patients treated with the

Zyvox(TM) Inventors Win Discoverers Award  -  Mar 16, 2007
PR-Inside.com (Pressemitteilung),Pfizer, Inc's revolutionary Zyvox(TM) is the first medicine in a new class of antibiotics that helps treat life-threatening infections caused by highly

Study shows more risk with Pfizer antibiotic: FDA  -  Mar 16, 2007
ReutersWASHINGTON (Reuters) - The US Food and Drug Administration on Friday issued a safety alert over Pfizer Inc.'s antibiotic Zyvox after a clinical trial found

Study shows more risk with Pfizer antibiotic-US FDA  -  Mar 16, 2007
ReutersN: Quote, Profile, Research) antibiotic Zyvox after a clinical trial found a higher chance of death in seriously ill patients given the drug.

Health ministry says 'risky antibiotic' is a restricted drug  -  Mar 20, 2007
Gulf News,The US Food and Drug Administration (FDA) issued a safety alert to infectious disease specialists on antibiotic linezolid, sold under brand name Zyvox by

UK orders Pfizer to withdraw antibiotic advert  -  Mar 7, 2007
Reuters.uk,N: Quote, Profile , Research) to withdraw a potentially misleading advertisement in the medical press for its Zyvox antibiotic .

Pfizer ordered to withdraw advert  -  Mar 7, 2007
Irish Times,The medicines agency in Britain has ordered Pfizer Inc to withdraw a potentially misleading advertisement in the medical press for its Zyvox antibiotic.

UK orders Pfizer to withdraw antibiotic advert  -  Mar 7, 2007
Scotsman,LONDON (Reuters) - The medicines agency has ordered Pfizer Inc to withdraw a potentially misleading advertisement in the medical press for its Zyvox

PhRMA to Present Clinical Trial Exceptional Service Award  -  Mar 9, 2007
PharmaLive.com (press release),Zyvox™ is used to help treat infections caused by life-threatening bacteria as well as pneumonia. More than one million patients worldwide have been helped

UK requests removal of Pfizer antibiotic advert  -  Mar 8, 2007
Pharmaceutical Business ReviewThe Medicines and Healthcare products Regulatory Agency (MHRA) has said the advert claims that Zyvox has superior cure rates compared to products containing

Off-Label Use of Linezolid Linked to Increased Death Risk  -  Mar 19, 2007
Medscape (subscription)March 19, 2007 — Use of linezolid (Zyvox; Pfizer, Inc) to treat patients with catheter-related bloodstream infection may be linked to an increased risk for

Superbugs driving blockbusters  -  Mar 7, 2007
Monsters and Critics.com,Zyvox sales are ramping up due to the rise of MRSA, and the drug will likely achieve blockbuster status in the next few years.

Pharmaceutical Company Ordered to Withdraw Advertising  -  Mar 7, 2007
PharmaLive.com (press release),The MHRA became aware of the advertisement in the British Medical Journal (BMJ) claiming that Zyvox has superior cure rates compared to products containing

FDA grants approval to Lipitor in five new indications  -  Mar 8, 2007
Pharma Times (subscription),The MHRA said it became aware of the advertisement in the British Medical Journal which claimed that Zyvox has superior cure rates compared to products

TradingMarkets 7 Stocks You Need to Know for Monday  -  Mar 16, 2007
Trading Markets,In more drug news, the FDA issued a safety alert warning over Pfizer's (PFE | charts | news | PowerRating) antibiotic Zyvox.

TradingMarkets 7 Stocks You Need to Know for Monday  -  Mar 16, 2007
Trading Markets,...test to distinguish between bacterial and viral meningitis. In more drug news, the FDA issued a safety alert warning over Pfizer's (PFE) antibiotic Zyvox.

Rise of the superbug set to drive antibacterials growth  -  Mar 9, 2007
Pharmaceutical Business Review...indicated for the treatment of resistant infections, and former niche antibiotics such as Pfizer's Zyvox (linezolid) on the verge of blockbuster status.

Council on Aging to hold first meeting  -  Mar 2, 2007
Reporter-Times,Michael Substanley, senior therapeutic specialty consultant from Pfizer will speak on Zyvox and Vfend. These medications can be provided for free to persons

Life won back by trial drug  -  Mar 17, 2007
Newsday,The drug, Zyvox, was in its first phase of safety and toxicity testing in adults. The doctor explained the urgency of the matter: a dying child who had

Pioneering treatment that won back a life  -  Mar 16, 2007
Newsday,The drug, Zyvox, was in its first phase of safety and toxicity testing in adults. The doctor explained the urgency of the matter: A dying child who had

Serotonin Poisoning Is Easily Overlooked  -  Mar 6, 2007
The Ledger,...triptans like Imitrex used to treat and prevent migraines; the antibiotic Zyvox (linezolide); antinausea drugs; the anti-Parkinson's drug L-dopa;

Mixing drugs could prove to be fatal  -  Mar 5, 2007
Worcester Telegram,...triptans such as Imitrex used to treat and prevent migraines; the antibiotic Zyvox (linezolide); antinausea drugs; the anti-Parkinson’s drug L-dopa;

Personal Health A Mix of Medicines That Can Be Lethal  -  Feb 26, 2007
New York Times,...triptans like Imitrex used to treat and prevent migraines; the antibiotic Zyvox (linezolide); antinausea drugs; the anti-Parkinson’s drug L-dopa;

Reporting Adverse Events for Drugs, Devices, Biologics and Dietary ...  -  Feb 12, 2007
eMaxHealth.com,Take the example of the antibiotic Zyvox. Within the first six months of Zyvox's marketing, FDA began getting MedWatch reports of myelosupression from

Serotonin Syndrome Precipitated by the Monoamine Oxidase Inhibitor ...  -  Jan 31, 2007
Am J Psychiatry (subscription)Zyvox (linezolid). http://www.zyvox.com/hcpConfirm.asp?hcp=check (Accessed July 2006). Lavery S, Ravi H, McDaniel WW, Pushkin YR: Linezolid and serotonin

Pediatric studies lead to more information on drug labels  -  Feb 1, 2007
AAP News (subscription)Zyvox (linezolid) is used to treat infections caused by bacteria that are resistant to other antibiotics (eg, Staphylococcus aureus (MRSA),

Commercial Insight: Antibacterials - Growth in resistance rates ...  -  Dec 19, 2006
Pharmaceutical Business ReviewThe fastest growing classes were the carbapenems, glycopeptides and "others" (eg Pfizer's Zyvox (linezolid)). The best selling drug was

Pfizer licences MRSA antibodies from Elusys  -  Jan 5, 2007
DrugResearcher.com,Pfizer currently has Zyvox (linezolid) indicated as a treatment for MRSA, and other bacterial infections, which had worldwide sales of $618m in 2005.

Commercial Insight: Antibacterials - Growth in resistance rates ...  -  Dec 19, 2006
Pharmaceutical Business Review...since 2001. The fastest growing classes were the carbapenems, glycopeptides and "others" (eg Pfizer's Zyvox (linezolid)). The best ...

UPDATE 2-Arpida shares surge on positive superbug drug trial  -  Nov 30, 2006
Reuters...as Zyvox. Iclaprim is designed to treat severe hospital-acquired infections including superbug MRSA. "The safety profile of iclaprim ...

Research and Markets : Pfizer Has a Broad Portfolio, With ...  -  Dec 19, 2006
Business Wire (press release),Pfizer also submitted several important sNDAs for new indications for existing products including the novel antibiotic, Zyvox, and the antifungal, Vfend. ...

Arpida's Iclaprim Jumps Over Hurdle, Hits In Phase III Study  -  Dec 5, 2006
BioWorld Online,...which attained the primary endpoint in the first of two Phase III clinical trials by demonstrating statistical non-inferiority to linezolid (Zyvox) in the ...

Arpida says skin drug shows benefits in trial  -  Nov 29, 2006
ReutersThe Phase III trials were designed to compare the efficacy and safety of iclaprim with that of market leader linezolid, marketed by Pfizer Inc. as Zyvox. ...

Arpida Announces Positive Results in First Phase III Trial of ...  -  Nov 30, 2006
PharmaLive.com (press release),Studies) clinical trial. In this Phase III trial, iclaprim was compared to linezolid, marketed by Pfizer as Zyvox®. The primary ...

Ex-Upjohn researchers to be honored for Zyvox  Oct 24, 2006
...two of whom now work for Pfizer Inc., have been granted an American Chemical Society award for their work in developing the antibiotic Zyvox while at The ... -MLive.com, Sweating the microscopic stuff: Former Tiffin man devotes life to ...  Oct 27, 2006
He and other members of the research team that discovered infection medication Zyvox are to receive the American Chemical Society’s 2007 National Award for ... -Tiffin Advertiser Tribune, Advanced BioHealing Builds Commercial Leadership Team  Oct 25, 2006
Mr. O'Briant was involved with such products as Trovan(R), Zyvox(R) and Diflucan(R) all products geared toward vascular surgeons, podiatrists and wound care ... -Earthtimes.org Pfizer to Transform In Rapidly Changing Healthcare Environment  Oct 19, 2006
548 29 474 323 47 232 225 4 CELEBREX 537 446 20 419 339 24 118 107 11 - INFECTIOUS AND RESPIRATORY DISEASES 836 1,074 (22) 285 533 (47) 551 541 2 ZYVOX 206 157 ... -Yahoo! News (press release) Theravance: Skin Deep Success?  Aug 25, 2006
...subset, this would have helped differentiate it from other intravenous antibiotics such as Cubist Pharmaceuticals' Cubicin, Pfizer's Zyvox and vancomycin ... -International News Service

Arpida's Iclaprim Jumps Over Hurdle, Hits In Phase III Study  -  Dec 5, 2006
BioWorld Online,...trials by demonstrating statistical non-inferiority to linezolid (Zyvox) in the treatment of complicated skin and skin-structure infection (CSSSi).

Arpida shares surge on positive superbug drug trial  -  Nov 30, 2006
Reuters..."The safety profile of iclaprim was excellent and here we believe that iclaprim offers a significant benefit over Zyvox which causes myelosuppression

UPDATE 1-Arpida shares rise on positive trial results  -  Nov 30, 2006
ReutersThe Phase III trials were designed to compare the efficacy and safety of iclaprim with that of market leader linezolid, marketed by Pfizer Inc. as Zyvox.

FDA panel to review safety of 16 drugs in children  -  Nov 15, 2006
MarketWatchOn Pfizer's Zyvox, which is indicated for treatment of certain bacterial infections, the FDA staff found six unlabeled events of "cardiac nature" during the

Arpida Announces Positive Results in First Phase III Trial of ...  -  Nov 30, 2006
PharmaLive.com (press release),In this Phase III trial, iclaprim was compared to linezolid, marketed by Pfizer as Zyvox®. The primary efficacy endpoint of statistical non-inferiority in

On Safety of 16 Drugs in Children  -  Nov 15, 2006
Wall Street Journal (subscription),Included in this group are Pfizer's Zyvox, GlaxoSmithKline PLC's Zofran and Avandia, Forest Laboratories Inc.'s Celexa, Novartis AG's Trileptal,

Theravance: Skin Deep Success?  Aug 25, 2006
...subset, this would have helped differentiate it from other intravenous antibiotics such as Cubist Pharmaceuticals' Cubicin, Pfizer's Zyvox and vancomycin ... -International News Service

CA-MRSA infections an increasing concern in early infancy  Aug 1, 2006
Virtually all strains also are susceptible to a recently Food and Drug Administration (FDA)-approved antibacterial, linezolid (Zyvox), available in both oral ... -AAP News (subscription)

Optimer Pharmaceuticals Appoints Kevin P. Poulos as Vice President ...  Aug 1, 2006
...his career, Mr. Poulos has lead the global commercialization activities of novel anti-infective classes and products such as Oxazolidinones (Zyvox(R)), Beta ... -Genetic Engineering News

Pfizer Delivers Strong Second-Quarter 2006 Results, Driven By ...  Jul 20, 2006
14 394 324 22 233 225 3 CELEBREX 471 401 17 355 306 16 116 95 22 - INFECTIOUS AND RESPIRATORY DISEASES 835 1,102 (24) 271 520 (48) 564 582 (3) ZYVOX 167 153 9 ... -PR Newswire

Reading between the handwriting  Jul 4, 2006
Like a handwriting detective, Luparello has to decipher terms such as Zyvox, Lipitor and Paxil; of course, medications dispensed improperly could spell all ... -Beaumont Enterprise

Kalamazoo is drug-testing hub for Pfizer  Jul 3, 2006
...worldwide. Cholesterol-lowering drug Lipitor, pain medicine Neurontin and antibiotic Zyvox were all discovered and developed in Michigan. ... -Detroit Free Press



International Approvals: Tygacil, DepoDur, and Zyvox  May 8, 2006
On April 24, Japan's Ministry of Health, Labor, and Welfare (MHLW) approved a new indication for linezolid 600-mg tablets and injection (Zyvox, made by Pfizer ... - Medscape (subscription)

Pfizer Japan Obtains Approval for ZYVOX, Detrusitol, J Zoloft in ...  Apr 24, 2006
Tokyo, Apr 24, 2006 (JCN) - Pfizer Japan announced on April 24 that it received approval for an additional indication for ZYVOX Tablets 600mg/ ZYVOX Injection ... - Japan Corporate News

Pfizer Japan Obtains Approval for ZYVOX, Detrusitol, J Zoloft in ...  Apr 25, 2006
Apr 24, 2006 (JCN Newswire via COMTEX) --Pfizer Japan announced on April 24 that it received approval for an additional indication for ZYVOX Tablets 600mg ... - Therapeutics Daily (subscription)

By Henry I. Miller/David Longtin  May 2, 2006
During the last 37 years, only two antibiotics with truly novel modes of action have been introduced -- Zyvox in 2000 and Cubicin in 2003, the latter of which ... - Washington Times

Pfizer First-Quarter 2006 Financial Results Reflect Operating and ...  Apr 19, 2006
...system disorders (Geodon up 32 percent, Relpax up 24 percent); arthritis and pain (Celebrex up 19 percent); infectious and respiratory diseases (Zyvox up 30 ... - International News Service

Germs just waiting for the right moment to attack  Apr 23, 2006
Infectious disease specialist Dr. Ellen Yang prescribed Zyvox, a relatively new microbial drug: 14 pills cost $198. ... Zyvox seems to be working. ... - Annapolis Capital

By HENRY I. MILLER & DAVID LONGTIN  Apr 23, 2006
The last 37 years have brought just two new antibiotics with truly novel modes of action - Zyvox in 2000 and Cubicin in 2003 (and Cubicin is only used for skin ... - New York Post

Coley Pharmaceutical Group Appoints Ferdinand E. Massari, MD ...  Apr 27, 2006
While at Pharmacia, he was responsible for the global clinical development of Zyvox, a novel antibiotic, which received regulatory approval in the US, Europe ... - Yahoo! News





The Hospital Antibacterial Market Presents New Opportunities for ...  Mar 15, 2006
With the availability of several products active against MRSA and VRE (eg, linezolid (Pfizer's Zyvox), daptomycin (Cubist's Cubicin)), the most significant ... - Genetic Engineering News

Arpida announces positive review by Data and Safety Monitoring ...  Mar 21, 2006
The global Phase III ASSIST trials are designed to compare the efficacy and safety of iclaprim with that of market leader linezolid (marketed by Pfizer as Zyvox ... - PharmaLive.com



The Most Dangerous Bacteria  Mar 1, 2006
In the past two years, there have been two: Zyvox, from Pfizer (nyse: PFE - news - people ), and Cubicin, from Cubist Pharmaceuticals (nasdaq: CBST - news ... - Forbes

Rising Risk of Epidemics Seen  Feb 20, 2006
...antibacterials by 2014, according to companies. Those drugs are Pfizer’s Zyvox, Johnson & Johnson’s Levaquin, and Wyeth’s Tygacil. - Red Herring,

Genomics in Antibacterial Drug Discovery  Feb 7, 2006
Development of resistance to every class of antibiotic, including the recently marketed Zyvox (linezolid) from Pfizer, is seriously limiting antibiotic options ... - Drug Discovery & Development (subscription)

Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect ...  Jan 19, 2006
Caduet up 272 percent); central nervous system disorders (Geodon up 26 percent, Relpax up 38 percent); infectious and respiratory diseases (Zyvox up 33 percent ... - PR Newswire

With Many Big Pharma Companies Recently Choosing to Withdraw From ...  Jan 26, 2006
With the availability of several products active against MRSA and VRE (eg, linezolid (Pfizer's Zyvox), daptomycin (Cubist's Cubicin)), the most significant ... - Genetic Engineering News

MCS Health Care Communications Appoints New Vice President  Jan 24, 2006
During his career, Bingham has helped launch such pharmaceutical products as Pharmacia's antibiotic Zyvox(r), GlaxoSmithKline's genital herpes drug Valtrex(r ... - PharmaLive.com

Chiron wins EU approval for IV antibiotic  Jan 24, 2006
The others are Pfizer's Zyvox (linezolid) and Sanofi-Aventis' Ketek (telithromycin; which hit the headlines itself yesterday after being linked to liver ... - Pharma Times (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional